Cargando…

Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience

BACKGROUND: Mucormycosis is an emerging fungal infection in both developed and developing countries with different target population. Unusual isolates and unusual clinical presentations have been reported from India in recent times. OBJECTIVES: The present study was done to know the epidemiology, ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Priya, Poorna, Ganesan, Vithiya, Rajendran, T, Geni, VG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225759/
https://www.ncbi.nlm.nih.gov/pubmed/32435094
http://dx.doi.org/10.5005/jp-journals-10071-23387
_version_ 1783534134389374976
author Priya, Poorna
Ganesan, Vithiya
Rajendran, T
Geni, VG
author_facet Priya, Poorna
Ganesan, Vithiya
Rajendran, T
Geni, VG
author_sort Priya, Poorna
collection PubMed
description BACKGROUND: Mucormycosis is an emerging fungal infection in both developed and developing countries with different target population. Unusual isolates and unusual clinical presentations have been reported from India in recent times. OBJECTIVES: The present study was done to know the epidemiology, risk factors, diagnostic modalities, and treatment outcome of mucormycosis patients in our hospital. MATERIALS AND METHODS: The study was carried out over a period of 4 years from October 2015 to October 2019. This is a retrospective observational chart review of patients diagnosed with proven and probable mucormycosis. Information on demography, clinical features, risk factors, laboratory and radiological findings, treatment (including medical and surgical treatment), and outcome was extracted from the records. Primary outcome at 42 days was determined. RESULTS: Thirty-eight patients were diagnosed with mucormycosis based on microbiological and/or histopathological examination (HPE) of the clinical samples. Most commonly affected age-group was between 41 years and 60 years. More number of cases were reported during the months of post rainy season (September to December). A large number of patients (77%) presented with uncontrolled diabetes mellitus. Rhino-orbito-cerebral mucormycosis was the most common presentation followed by cutaneous infection. Antifungal treatment was started in around 80% of the cases. Twenty patients were managed by combined medical and surgical intervention. Eight patients died while the outcome of nine was unknown, as they left the hospital against medical advice and could not be followed up. CONCLUSION: Mucormycosis, an insidious killer, should be an important differential diagnosis in progressive soft tissue infections and deep organ infection. HOW TO CITE THIS ARTICLE: Priya P, Ganesan V, Rajendran T, Geni VG. Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience. Indian J Crit Care Med 2020;24(3):168–171.
format Online
Article
Text
id pubmed-7225759
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-72257592020-05-20 Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience Priya, Poorna Ganesan, Vithiya Rajendran, T Geni, VG Indian J Crit Care Med Original Article BACKGROUND: Mucormycosis is an emerging fungal infection in both developed and developing countries with different target population. Unusual isolates and unusual clinical presentations have been reported from India in recent times. OBJECTIVES: The present study was done to know the epidemiology, risk factors, diagnostic modalities, and treatment outcome of mucormycosis patients in our hospital. MATERIALS AND METHODS: The study was carried out over a period of 4 years from October 2015 to October 2019. This is a retrospective observational chart review of patients diagnosed with proven and probable mucormycosis. Information on demography, clinical features, risk factors, laboratory and radiological findings, treatment (including medical and surgical treatment), and outcome was extracted from the records. Primary outcome at 42 days was determined. RESULTS: Thirty-eight patients were diagnosed with mucormycosis based on microbiological and/or histopathological examination (HPE) of the clinical samples. Most commonly affected age-group was between 41 years and 60 years. More number of cases were reported during the months of post rainy season (September to December). A large number of patients (77%) presented with uncontrolled diabetes mellitus. Rhino-orbito-cerebral mucormycosis was the most common presentation followed by cutaneous infection. Antifungal treatment was started in around 80% of the cases. Twenty patients were managed by combined medical and surgical intervention. Eight patients died while the outcome of nine was unknown, as they left the hospital against medical advice and could not be followed up. CONCLUSION: Mucormycosis, an insidious killer, should be an important differential diagnosis in progressive soft tissue infections and deep organ infection. HOW TO CITE THIS ARTICLE: Priya P, Ganesan V, Rajendran T, Geni VG. Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience. Indian J Crit Care Med 2020;24(3):168–171. Jaypee Brothers Medical Publishers 2020-03 /pmc/articles/PMC7225759/ /pubmed/32435094 http://dx.doi.org/10.5005/jp-journals-10071-23387 Text en Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Priya, Poorna
Ganesan, Vithiya
Rajendran, T
Geni, VG
Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
title Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
title_full Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
title_fullStr Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
title_full_unstemmed Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
title_short Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
title_sort mucormycosis in a tertiary care center in south india: a 4-year experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225759/
https://www.ncbi.nlm.nih.gov/pubmed/32435094
http://dx.doi.org/10.5005/jp-journals-10071-23387
work_keys_str_mv AT priyapoorna mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience
AT ganesanvithiya mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience
AT rajendrant mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience
AT genivg mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience